% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Doering:281527,
author = {Doering, Elena and Hoenig, Merle C and Cole, James H and
Drzezga, Alexander},
title = {{W}hen {A}ge {I}s {M}ore {T}han a {N}umber: {A}cceleration
of {B}rain {A}ging in {N}eurodegenerative {D}iseases.},
journal = {Journal of nuclear medicine},
volume = {66},
number = {10},
issn = {0097-9058},
address = {New York, NY},
publisher = {Soc.},
reportid = {DZNE-2025-01145},
pages = {1516 - 1521},
year = {2025},
abstract = {Aging of the brain is characterized by deleterious
processes at various levels including cellular/molecular and
structural/functional changes. Many of these processes can
be assessed in vivo by means of modern neuroimaging
procedures, allowing the quantification of brain age in
different modalities. Brain age can be measured by suitable
machine learning strategies. The deviation (in both
directions) between a person's measured brain age and
chronologic age is referred to as the brain age gap (BAG).
Although brain age, as defined by these methods, generally
is related to the chronologic age of a person, this
relationship is not always parallel and can also vary
significantly between individuals. Importantly, whereas
neurodegenerative disorders are not equivalent to
accelerated brain aging, they may induce brain changes that
resemble those of older adults, which can be captured by
brain age models. Inversely, healthy brain aging may involve
a resistance or delay of the onset of neurodegenerative
pathologies in the brain. This continuing education article
elaborates how the BAG can be computed and explores how
BAGs, derived from diverse neuroimaging modalities, offer
unique insights into the phenotypes of age-related
neurodegenerative diseases. Structural BAGs from T1-weighted
MRI have shown promise as phenotypic biomarkers for
monitoring neurodegenerative disease progression especially
in Alzheimer disease. Additionally, metabolic and molecular
BAGs from molecular imaging, functional BAGs from functional
MRI, and microstructural BAGs from diffusion MRI, although
researched considerably less, each may provide distinct
perspectives on particular brain aging processes and their
deviations from healthy aging. We suggest that BAG
estimation, when based on the appropriate modality, could
potentially be useful for disease monitoring and offer
interesting insights concerning the impact of therapeutic
interventions.},
subtyp = {Review Article},
keywords = {Humans / Neurodegenerative Diseases: diagnostic imaging /
Neurodegenerative Diseases: physiopathology /
Neurodegenerative Diseases: pathology / Aging: pathology /
Brain: diagnostic imaging / Brain: pathology / Brain:
physiopathology / Neuroimaging: methods / Magnetic Resonance
Imaging / Machine Learning / brain age (Other) / dementia
(Other) / machine learning (Other) / neurodegeneration
(Other) / neuroimaging (Other)},
cin = {AG Boecker},
ddc = {610},
cid = {I:(DE-2719)1011202},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40841153},
pmc = {pmc:PMC12487868},
doi = {10.2967/jnumed.125.270325},
url = {https://pub.dzne.de/record/281527},
}